[{"indications": "Indications\u00a0diabetes\r\nmellitus (see notes above); polycystic ovary syndrome [unlicensed\r\nindication]", "name": "METFORMIN HYDROCHLORIDE Modified release", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.1 Drugs used in diabetes", "6.1.2 Antidiabetic drugs", "6.1.2.2 Biguanides", "METFORMIN HYDROCHLORIDE", "Modified release"], "cautions": "Cautions\u00a0\n(From 6.1.2.2 Biguanides: British National Formulary)\nVery rarely, metformin can provoke lactic acidosis. It is most likely to occur in patients with renal impairment, see Lactic Acidosis below.Metformin is used for the symptomatic management of polycystic ovary syndrome [unlicensed indication]; however, treatment should be initiated by a specialist. Metformin improves insulin sensitivity, may aid weight reduction, helps to normalise menstrual cycle (increasing the rate of spontaneous ovulation), and may improve hirsutism.; determine renal function before treatment and at least annually (at\r\nleast twice a year in patients with additional risk factors for renal\r\nimpairment, or if deterioration suspected); interactions: Appendix 1 (antidiabetics)Lactic acidosis\u00a0Use with caution\r\nin renal impairment\u2014increased risk of lactic acidosis; avoid in significant renal impairment. NICE%s\n(From Metformin: British National Formulary)\n(1)NICE clinical guideline 87 (May 2009): Type 2 diabetes: The management of type 2 diabetes recommends that the dose\r\nshould be reviewed if eGFR less than 45\u00a0mL/minute/1.73\u00a0m2 and to avoid if eGFR less than 30\u00a0mL/minute/1.73\u00a0m2. Withdraw or interrupt treatment\r\nin those at risk of tissue hypoxia or sudden deterioration in renal\r\nfunction, such as those with dehydration, severe infection, shock,\r\nsepsis, acute heart failure, respiratory failure or hepatic impairment,\r\nor those who have recently had a myocardial infarction", "side-effects": "Side-effects\u00a0anorexia, nausea, vomiting, diarrhoea (usually\r\ntransient), abdominal pain, taste disturbance, rarely lactic acidosis (withdraw treatment), decreased vitamin-B12 absorption, erythema, pruritus and urticaria; hepatitis also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/201498.htm", "doses": ["Diabetes mellitus, adult and child over 10 years initially\r\n500\u00a0mg with breakfast for at least 1 week then 500\u00a0mg with breakfast\r\nand evening meal for at least 1 week then 500\u00a0mg with breakfast, lunch\r\nand evening meal; usual max. 2\u00a0g daily in divided doses", "Polycystic ovary syndrome [unlicensed], initially 500\u00a0mg with\r\nbreakfast for 1 week, then 500\u00a0mg with breakfast and evening meal\r\nfor 1 week, then 1.5\u20131.7\u00a0g daily in 2\u20133 divided doses", "Metformin doses in the BNF may differ from\r\nthose in the product literature", "Name[Metformin (Non-Proprietary)] Tablets, m/r, metformin hydrochloride 500\u00a0mg, net price 28 tab-pack = \u00a33.07, 56 tab-pack\r\n= \u00a36.14. \r\n    Label:\r\n    21, 25Dose\u00a0initially 500\u00a0mg once daily, increased every 10\u201315 days,\r\nmax. 2\u00a0g once daily with evening meal; if control not achieved, use\r\n1\u00a0g twice daily with meals, and if control still not achieved change\r\nto standard-release tabletsNote\u00a0Patients taking up to 2\u00a0g daily of the standard-release metformin may start with the same daily dose of metformin\r\nmodified release; not suitable if dose of standard-release tablets\r\nmore than 2\u00a0g dailyBrands include Bolamyn\u00ae SR, Glucient\u00ae SR, Metabet\u00ae SR"], "pregnancy": "Pregnancy\u00a0used in pregnancy for both pre-existing and gestational\r\ndiabetes\u2014see also section 6.1.2"}, {"indications": "Indications\u00a0diabetes\r\nmellitus (see notes above); polycystic ovary syndrome [unlicensed\r\nindication]", "name": "METFORMIN HYDROCHLORIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.1 Drugs used in diabetes", "6.1.2 Antidiabetic drugs", "6.1.2.2 Biguanides", "METFORMIN HYDROCHLORIDE"], "cautions": "Cautions\u00a0\n(From 6.1.2.2 Biguanides: British National Formulary)\nVery rarely, metformin can provoke lactic acidosis. It is most likely to occur in patients with renal impairment, see Lactic Acidosis below.Metformin is used for the symptomatic management of polycystic ovary syndrome [unlicensed indication]; however, treatment should be initiated by a specialist. Metformin improves insulin sensitivity, may aid weight reduction, helps to normalise menstrual cycle (increasing the rate of spontaneous ovulation), and may improve hirsutism.; determine renal function before treatment and at least annually (at\r\nleast twice a year in patients with additional risk factors for renal\r\nimpairment, or if deterioration suspected); interactions: Appendix 1 (antidiabetics)Lactic acidosis\u00a0Use with caution\r\nin renal impairment\u2014increased risk of lactic acidosis; avoid in significant renal impairment. NICE%s\n(From Modified release: British National Formulary)\n(1)NICE clinical guideline 87 (May 2009): Type 2 diabetes: The management of type 2 diabetes recommends that the dose\r\nshould be reviewed if eGFR less than 45\u00a0mL/minute/1.73\u00a0m2 and to avoid if eGFR less than 30\u00a0mL/minute/1.73\u00a0m2. Withdraw or interrupt treatment\r\nin those at risk of tissue hypoxia or sudden deterioration in renal\r\nfunction, such as those with dehydration, severe infection, shock,\r\nsepsis, acute heart failure, respiratory failure or hepatic impairment,\r\nor those who have recently had a myocardial infarction", "side-effects": "Side-effects\u00a0anorexia, nausea, vomiting, diarrhoea (usually\r\ntransient), abdominal pain, taste disturbance, rarely lactic acidosis (withdraw treatment), decreased vitamin-B12 absorption, erythema, pruritus and urticaria; hepatitis also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129176.htm", "doses": ["Diabetes mellitus, adult and child over 10 years initially\r\n500\u00a0mg with breakfast for at least 1 week then 500\u00a0mg with breakfast\r\nand evening meal for at least 1 week then 500\u00a0mg with breakfast, lunch\r\nand evening meal; usual max. 2\u00a0g daily in divided doses", "Polycystic ovary syndrome [unlicensed], initially 500\u00a0mg with\r\nbreakfast for 1 week, then 500\u00a0mg with breakfast and evening meal\r\nfor 1 week, then 1.5\u20131.7\u00a0g daily in 2\u20133 divided doses", "Metformin doses in the BNF may differ from\r\nthose in the product literature"], "pregnancy": "Pregnancy\u00a0used in pregnancy for both pre-existing and gestational\r\ndiabetes\u2014see also section 6.1.2"}]